Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts
Published on: 23 March 2017
Published on: 23 March 2017
Published on: 16 March 2017
Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo
Published on: 15 February 2006
Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics Concluding remarks
Published on: 16 April 2013
Published on: 24 November 2012
Published on: 7 February 2015
Published on: 13 November 2013
Aims and scope
Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.
Alaina Ammit, University of Technology Sydney, Australia
Robert Bals, Saarland University, Germany
Francesco Blasi, University of Milan, Italy
Arnaud Bourdin, University of Montpellier, France
Mario Cazzola, Antonio Cardarelli Hospital, Italy
Bruno Crestani, Bichat Hospital, France
Jeanine D'Armiento, Columbia University College of Physicians and Surgeons, USA
Massimo Di Maio, University of Turin, Italy
Louise Donnelly, Imperial College London, UK
Reinoud Gosens, University of Groningen, Netherlands
Hiromasa Inoue, Kagoshima University, Japan
Victor Kim, Temple University School of Medicine, USA
Stylianos Orfanos, National and Kapodistrian University of Athens, Greece
Stephen Peters, Wake Forest University Health Sciences, USA
YS Prakash, Mayo Clinic, USA
David Price, University of Aberdeen, UK
Sundeep Salvi, Chest Research Foundation, India
Dale D Tang, Albany Medical College, USA
Johan Verbraecken, Antwerp University Hospital, Belgium
Featured review: Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation
Respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD) are characterised by excessive and persistent inflammation. Current treatments are often inadequate for symptom and disease control, and hence new therapies are warranted. Recent emerging research has implicated dyslipidaemia in pulmonary inflammation. Understanding the relationship between cholesterol and inflammation in the lung, and the role that ABC transporters play in this may illuminate new pathways to target for the treatment of inflammatory lung diseases.
Professor at the Department of Internal Medicine, and Chairman of the Krefting Research Centre at the University of Gothenburg.
Submit your review
Sign up to receive article alerts
Respiratory Research is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.